Physician Assistant · Riverside, CA
NPI
1124457015
Since 2013
Specialty
Physician Assistant
Code 363A00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
5225 Canyon Crest Dr # 71-221
Riverside, CA, 92507
Phone (951) 202-4578
Groups this clinician bills Medicare through
Medicare paid, 2024
$126K
1,649 services
Medicare patients, 2024
337
Average age 75
Drug cost, 2024
$3.0M
4,143 prescriptions
Company payments, 2025
$975
From 12 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Tiffany Peraino was code 99214 (office e&m - established), 759 times for 284 patients. In total Tiffany Peraino billed 1,649 services in 19 codes, and Medicare paid $126K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-04-14.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 759 | 284 | $86.36 | $66K |
| 99309 SNF E&M | Facility | 519 | 24 | $71.90 | $37K |
| 99215 Office E&M - Established | Office | 114 | 76 | $121.55 | $14K |
| 94618 Pulmonary Function Testing | Office | 101 | 88 | $23.40 | $2,364 |
| 99406 Behavioral Health Services | Office | 46 | 13 | $12.65 | $582 |
| 99213 Office E&M - Established | Office | 39 | 35 | $51.18 | $1,996 |
| 99204 Office E&M - New | Office | 23 | 23 | $103.84 | $2,388 |
| 94010 Pulmonary Function Testing | Office | 14 | 11 | $16.66 | $233 |
By year: 2022 $198K for 2,684 services; 2023 $188K for 2,379 services; 2024 $126K for 1,649 services.
Medicare prescription drug claims, 2024
In 2024, the drug Tiffany Peraino prescribed most often to Medicare patients was Montelukast Sodium, with 581 prescriptions and refills. In total Tiffany Peraino wrote 4,143 Medicare prescriptions that cost $3.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Montelukast Sodium Generic | 581 | 1,323 | 185 | $6,187 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 401 | 474 | 152 | $14K |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 377 | 544 | 94 | $331K |
| Azelastine Hcl Generic | 285 | 414 | 100 | $6,780 |
| Azithromycin Generic | 246 | 345 | 101 | $3,088 |
| Fluticasone Propionate Generic | 233 | 390 | 84 | $2,927 |
| Prednisone Generic | 190 | 223 | 90 | $487 |
| Anoro Ellipta Umeclidinium Brm/Vilanterol Tr | 112 | 149 | 37 | $66K |
| Breztri Aerosphere Budesonide/Glycopyr/Formoterol | 95 | 120 | 36 | $72K |
| Ventolin Hfa Albuterol Sulfate | 80 | 89 | 23 | $5,504 |
| Omeprazole Generic | 79 | 157 | 27 | $542 |
| Doxycycline Hyclate Generic | 74 | 74 | 55 | $448 |
| Nucala Mepolizumab | 71 | 76 | Under 11 | $428K |
| Wixela Inhub Fluticasone Propion/Salmeterol | 68 | 90 | 19 | $10K |
| Famotidine Generic | 63 | 138 | 25 | $563 |
Brand drugs: 1,522 claims; generic drugs: 2,621 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Tiffany Peraino $975 ($975 in general payments such as food, travel and fees) from 12 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $222.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 6 | $222 |
| GlaxoSmithKline, LLC. GSK | 21 | $207 |
| Baxter Healthcare BAX | 7 | $184 |
| ViiV Healthcare Company GSK | 3 | $92.53 |
| Abbvie Inc. ABBV | 3 | $76.77 |
| Genzyme Corporation SNY | 1 | $39.28 |
| Inspire Medical Systems, Inc. INSP | 1 | $34.68 |
| Regeneron Healthcare Solutions, Inc. REGN | 1 | $31.07 |
| Paratek Pharmaceuticals, Inc. | 1 | $30.78 |
| Lilly USA, LLC LLY | 1 | $21.56 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.